News

AbbVie Secures FDA Approval to Expand Mavyret’s Label
AbbVie Inc. (NYSE:ABBV) is one of the best stocks for a dividend stock portfolio. The company announced that the US FDA has ...
GlobalData on MSN3d
FDA approves label expansion of AbbVie hepatitis C therapy
The US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir) for treating adults and paediatric patients three years and older with acute ...
Targeted Oncology3d
FDA Greenlights Perioperative Pembrolizumab in Resectable HNSCC
The FDA has granted approval to pembrolizumab for the treatment of adult patients with resectable, locally advanced HNSCC ...
Pharmabiz2d
AbbVie’s Mavyret receives US FDA label expansion approval for treatment of chronic hepatitis C virus
AbbVie’s Mavyret receives US FDA label expansion approval for treatment of chronic hepatitis C virus: North Chicago Saturday, June 14, 2025, 11:00 Hrs [IST] AbbVie announced tha ...
Medical Dialogues13h
FDA Approves Keytruda as First Immune Checkpoint Inhibitor for Resectable Locally Advanced Head and Neck Cancer
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...
MedPage Today on MSN4d
Polypill Approved for Hypertension, Including as Initial Therapy
The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...
Gizmodo1mon
The FDA Just Approved CRISPR-Edited Pigs for the Dinner Table
The FDA has deemed PIC's gene edit ... in the commercial market once approved. That said, the relatively simple nature of PIC’s method (removing, not adding a gene) and the large-scale benefits ...
MPR13h
Brukinsa Tablets Get FDA Nod for All Approved Indications
The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct ...
There's a New Botox Alternative on the Block
Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack ...
Managed Healthcare Executive3d
FDA Approves Ibtrozi For Adults With ROS1+ NSCLC
Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell ...